scholarly journals Lung cancer screening in China: early-stage lung cancer and minimally invasive surgery 3.0

2018 ◽  
Vol 10 (S14) ◽  
pp. S1677-S1679 ◽  
Author(s):  
Difan Zheng ◽  
Haiquan Chen
Keyword(s):  
Lung Cancer ◽  
Minimally Invasive Surgery ◽  
Cancer Screening ◽  
Minimally Invasive ◽  
Invasive Surgery ◽  
Early Stage ◽  
Lung Cancer Screening ◽  
Early Stage Lung Cancer ◽  
Stage Lung Cancer

Do minimally invasive approaches increase the survival of patients with early-stage lung cancer undergoing lobectomy

2016 ◽  
Vol 1 ◽  
pp. 18-18
Author(s):  
Benoît Bédat ◽  
Wolfram Karenovics ◽  
Samira Mercedes Sadowski ◽  
Frédéric Triponez
Keyword(s):  
Lung Cancer ◽  
Minimally Invasive ◽  
Early Stage ◽  
Early Stage Lung Cancer ◽  
Stage Lung Cancer

scholarly journals Minimally invasive segmentectomy for early stage lung cancer gains momentum

2019 ◽  
Vol 7 (3) ◽  
pp. 62-62
Author(s):  
Syed S. Razi ◽  
Dao Nguyen ◽  
Nestor Villamizar
Keyword(s):  
Lung Cancer ◽  
Minimally Invasive ◽  
Early Stage ◽  
Early Stage Lung Cancer ◽  
Stage Lung Cancer

scholarly journals A case of early stage lung cancer detected by repeated cancer screening with positron emission tomography

2011 ◽  
Vol 3 (2) ◽  
pp. 297-299 ◽  
Author(s):  
IKUKO SAKATA ◽  
YUICHI OZEKI ◽  
KATSUMI TAMURA ◽  
JIRO ISHIDA ◽  
SHINSUKE AIDA ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Positron Emission Tomography ◽  
Cancer Screening ◽  
Early Stage ◽  
Emission Tomography ◽  
Early Stage Lung Cancer ◽  
Positron Emission ◽  
Stage Lung Cancer

scholarly journals The Role of Minimally Invasive Surgery in the Treatment of Lung Cancer

2021 ◽  
Author(s):  
Güntuğ Batihan ◽  
Kenan Can Ceylan
Keyword(s):  
Lung Cancer ◽  
Minimally Invasive ◽  
Early Stage ◽  
Locally Advanced ◽  
Length Of Hospital Stay ◽  
Vats Lobectomy ◽  
Early Stage Lung Cancer ◽  
Oncologic Results ◽  
Stage Lung Cancer

Lobectomy plus regional lymph node dissection remains the gold standard treatment method in early-stage lung cancer. However, with the demonstration of the safety and efficacy of minimally invasive approaches, the expression of surgery in this statement, replaced by thoracoscopic anatomical lung resection. Clinical studies have demonstrated the superiority of VATS in terms of postoperative pain, drainage time, length of hospital stay, and complications, moreover, long-term oncologic results are similar or better than thoracotomy. Therefore, VATS lobectomy is the preferred surgical method in early-stage lung cancer. Different surgical techniques are available in VATS and can be modified according to the surgeon’s personal experience. Uniport can be applied as well as two or three port incisions. In this book section, I plan to focus on VATS lobectomy, technique-related tricks, complication management, and long-term oncologic results in early and locally advanced lung cancer.

LOW-DOSE COMPUTED TOMOGRAPHY IN MOSCOW FOR LUNG CANCER SCREENING (LDCT-MLCS): BASELINE RESULTS

2019 ◽  
Vol 65 (2) ◽  
pp. 224-233
Author(s):  
Sergey Morozov ◽  
Viktor Gombolevskiy ◽  
Anton Vladzimirskiy ◽  
Albina Laypan ◽  
Pavel Kononets ◽  
...  
Keyword(s):  
Computed Tomography ◽  
Lung Cancer ◽  
Cancer Screening ◽  
Low Dose ◽  
Early Stage ◽  
Lung Cancer Screening ◽  
Stage I ◽  
Malignant Neoplasms ◽  
Number Needed To Screen ◽  
Low Dose Computed Tomography

Study aim. To justify selective lung cancer screening via low-dose computed tomography and evaluate its effectiveness. Materials and methods. In 2017 we have concluded the baseline stage of “Lowdose computed tomography in Moscow for lung cancer screening (LDCT-MLCS)” trial. The trial included 10 outpatient clinics with 64-detector CT units (Toshiba Aquilion 64 and Toshiba CLX). Special low-dose protocols have been developed for each unit with maximum effective dose of 1 mSv (in accordance with the requirements of paragraph 2.2.1, Sanitary Regulations 2.6.1.1192-03). The study involved 5,310 patients (53% men, 47% women) aged 18-92 years (mean age 62 years). Diagnosis verification was carried out in the specialized medical organizations via consultations, additional instrumental, laboratory as well as pathohistological studies. The results were then entered into the “National Cancer Registry”. Results. 5310 patients (53% men, 47% women) aged 18 to 92 years (an average of 62 years) participated in the LDCT-MLCS. The final cohort was comprised of 4762 (89.6%) patients. We have detected 291 (6.1%) Lung-RADS 3 lesions, 228 (4.8%) Lung- RADS 4A lesions and 196 (4.1%) Lung-RADS 4B/4X lesions. All 4B and 4X lesions were routed in accordance with the project's methodology and legislative documents. Malignant neoplasms were verified in 84 cases (1.76% of the cohort). Stage I-II lung cancer was actively detected in 40.3% of these individuals. For the first time in the Russian Federation we have calculated the number needed to screen (NNS) to identify one lung cancer (NNS=57) and to detect one Stage I lung cancer (NNS=207). Conclusions. Based on the global experience and our own practices, we argue that selective LDCT is the most systematic solution to the problem of early-stage lung cancer screening.

Sign in / Sign up

Export Citation Format

Share Document